US EditionFDA Approves Merck's BRAVECTO QUANTUM Annual Flea And Tick Shot For Dogs
UNITED STATES, JUL 10 – BRAVECTO QUANTUM offers dogs 8 to 12 months of flea and tick protection with a single injection, improving convenience and safety, FDA approved on July 10, 2025.
- On Thursday, July 10, 2025, the FDA approved Merck Animal Health’s Bravecto Quantum, an injectable medication that provides dogs six months and older with protection against fleas and ticks lasting between 8 and 12 months.
- The approval responds to growing tick bite incidents by offering a long-acting alternative to monthly or quarterly treatments, requiring administration by licensed veterinarians who determine treatment duration based on local tick species.
- Bravecto Quantum uses fluralaner, an isoxazoline drug, and Merck highlights its leadership in long-acting parasiticides that provide convenient, year-round protection through a single veterinary injection.
- Merck cautions use in dogs with neurologic disorders due to potential side effects like seizures; advocates and experts advise pet owners to consult veterinarians to ensure safe, tailored use.
- Vet clinics will offer Bravecto Quantum starting August 2025, marking a new standard in flea and tick prevention amid a national rise in tick bite-related ER visits and expanding Merck’s global presence in over 50 countries.
21 Articles
21 Articles
Blockbuster long acting flea and tick treatment for dogs coming after FDA approval
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).The approval of the new injectable treatment, called Bravecto Quantum, was announced by the federal agency on Thursday.It is the "first FDA-approved drug that protects dogs against fleas and ticks for 8 to 12 months," according to the FDA. Bravecto Quantum can be used for treating and pre…
FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough
STOCK PHOTO/Getty Images (WASHINGTON) — Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick preventative that can protect dogs for up to 12 months with a single injection. The treatment is approved for dogs and puppies 6 months and ol…
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
